Pharmafile Logo
Pharmafocus logo
Advanced Search
160607140346-genentech-lung-cancer-drug-settlement-exlarge-169

Genentech’s cancer drug gets Breakthrough Therapy Designation from FDA

January 5, 2021
Manufacturing and Production Cancer, Genentech

Genentech has announced that tiragolumab, a novel cancer immunotherapy designed to bind to T cell immunoreceptor with Ig and ITIM …

News

Emergex to collaborate with Bio-Manguinhos on new COVID-19 vaccine

January 5, 2021
Manufacturing and Production COVID-19, Vaccine

Emergex, a company focusing on the development of medicines against viral and bacterial infectious diseases, has announced a collaboration and …

News

Scientists develop new drug to target KRAS mutations in cancer

January 5, 2021
Manufacturing and Production Cancer, Cancer Research UK

In a study funded by Cancer Research UK and Wellcome, scientists have developed a new drug that effectively targets the …

News
pfizer_building_logo1

EU states to receive 100m extra doses of Pfizer-BioNTech vaccine

January 4, 2021
Sales and Marketing COVID-19, EU, Pfizer, Vaccine

Pfizer and BioNTech have announced they will supply an additional 100 million doses of their COVID-19 vaccine, COMIRNATY, to the …

News
vaccination

Concern as India approves COVID-19 vaccine before trial completion

January 4, 2021
Sales and Marketing COVID-19, Vaccine

Experts have expressed concern over India’s emergency approval of its homegrown COVID-19 vaccine, Covaxin, before studies have been completed. The …

News
static

Moderna’s COVID-19 vaccine achieves over 90% efficacy in Phase III trial

January 4, 2021
Sales and Marketing COVID-19, Moderna

Moderna’s COVID-19 vaccine has achieved over 90% efficacy in interim safety and primary efficacy results following its Phase III trial. …

News
opaganib-bottle-and-tablets

RedHill announces positive top-line data for COVID-19 pneumonia drug

January 4, 2021
Sales and Marketing COVID-19

RedHill Biopharma has announced that preliminary top-line data from its US Phase II study with orally-administered opaganib (Yeliva) in patients …

News
astrazeneca-sign

UK becomes first country to roll out Oxford University-AstraZeneca COVID-19 vaccine

January 4, 2021
Sales and Marketing AstraZeneca, COVID-19, Vaccine

The UK has become the first country to administer the Oxford University-AstraZeneca COVID-19 vaccine to its population as coronavirus case …

News
top_10_image_2_1_5

Pharmafile.com’s top 10 stories of 2020

December 23, 2020
Research and Development

The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …

News

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020
Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …

News
european_commission_web

Zogenix gets EU marketing authorisation for anti-seizure drug

December 23, 2020
Research and Development

The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …

News
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 23, 2020
Research and Development COVID-19, Vaccine

The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …

News

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020
Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …

News
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …

Appointment
316616076-s-2-640x360

Polyphor granted Clinical Trial Authorisation for inhaled antibiotic

December 22, 2020
Manufacturing and Production Polyphor, cystic fibrosis

Polyphor, a Swiss clinical-stage biopharmaceutical company, has announced that the MHRA has granted a Clinical Trial Authorisation (CTA) to begin …

News

Pfizer and Moderna test COVID-19 vaccines against new strain

December 22, 2020
Manufacturing and Production COVID-19, Moderna, Pfizer, Vaccine

Pfizer and Moderna have begun testing their COVID-19 vaccines against the new, fast-spreading strain of the virus that was recently …

News
genentech_web

Genentech announces positive Phase III results for faricimab

December 22, 2020
Manufacturing and Production

Genentech, a member of the Roche group, today announced positive top-line results from two identically designed global Phase III studies …

News
8

Kobayashi Kako under inspection over contaminated medicines

December 22, 2020
Manufacturing and Production Kobayashi Kako, rilmazafone

Japanese pharmaceutical firm Kobayashi Kako is under inspection by authorities after it emerged that the company adopted illegal manufacturing procedures …

News
credit_-_daniel_leal-olivas-afp

EU gives green light to Pfizer-BioNTech COVID-19 vaccine

December 22, 2020
Manufacturing and Production COVID-19, EMA, Pfizer, Vaccine

The EMA has recommended the Pfizer-BioNTech COVID-19 vaccine for use across the EU’s 27 countries, with the first doses set …

News

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …

Feature
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025